Rationale for adjuvant chemotherapy

Cancer. 1977 Jun;39(6 Suppl):2875-82. doi: 10.1002/1097-0142(197706)39:6<2875::aid-cncr2820390675>3.0.co;2-7.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Carmustine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Doxorubicin / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Floxuridine / therapeutic use
  • Fluorouracil / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / surgery
  • Mammary Neoplasms, Experimental / drug therapy
  • Mice
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / surgery

Substances

  • Antineoplastic Agents
  • Floxuridine
  • Cytarabine
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil
  • Carmustine